Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    9817404 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury
Condition: Spinal Cord Injury
Interventions: Drug: methylprednisolone;   Drug: tirilazad

Indicates status has not been verified in more than two years